Reading SEM? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track SEM free→Reading SEM? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track SEM free→QuarterlyIQ Insights · SEM
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition. On April 30, 2026, Select Medical Holdings Corporation (the “Company”) issued a press release announcing its financial results for its first quarter ended March 31, 2026 (the “Press Release”). A copy of the Press Release and the attached financial schedules are attached as Exhibit 99.1 to this report and incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April, 28 2026, the Human Capital and Compensation Committee of the Board of Directors of the Company (the “Compensation Committee”) approved the deferral of the scheduled vesting dates of certain previously granted equity awards held by Robert A. Ortenzio, our Executive Chairman and Co-Founder, and Martin F. Jackson, our Senior Executive Vice P…
Other Events Dividend Declaration On April 29, 2026, the Company’s board of directors declared a cash dividend of $0.0625 per share. The dividend will be payable on or about May 28, 2026 to stockholders of record as of the close of business on May 14, 2026.
Entry into a Material Definitive Agreement. Agreement and Plan of Merger On March 2, 2026, Select Medical Holdings Corporation (the “ Company ” or “ Select Medical ”) entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Stallion Intermediate Corporation, a Delaware corporation (“ Parent ”), and Stallion MergerSub Corporation, a Delaware corporation and a wholly-owned subsidiary of Parent (“ Merger Sub ”). The Merger Agreement provides, among other things and on the ter…
Regulation FD Disclosure . On March 2, 2026, the Company issued a press release announcing the execution of the Merger Agreement. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference…
Results of Operations and Financial Condition. On February 19, 2026, Select Medical Holdings Corporation (the “Company”) issued a press release announcing its financial results for its fourth quarter and fiscal year ended December 31, 2025 (the “Press Release”). A copy of the Press Release and the attached financial schedules are attached as Exhibit 99.1 to this report and incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to
Other Events Dividend Declaration On February 12, 2026, the Company’s board of directors declared a cash dividend of $0.0625 per share. The dividend will be payable on or about March 12, 2026 to stockholders of record as of the close of business on March 2, 2026.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.